AnodyneWiki

Amobarbital

Amobarbital
Amobarbital
Salts
[]
Sodium amobarbital
Sodium amobarbital
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass226.27 g/mol [1]
AppearanceCrystals [1]
OdorOdorless [1]
TasteSlightly bitter [1]
Melting point313 to 316 °F (NTP, 1992) [1]
DecompositionWhen heated to decomposition, it emits toxic fumes of /nitric oxides/. [1]
Solubilityless than 1 mg/mL at 65.3 °F (NTP, 1992) [1]
Predicted LogP2.1 [1]
Structural Identifiers
[]
Molecular formulaC11H18N2O3
IUPAC name5-ethyl-5-(3-methylbutyl)-1,3-diazinane-2,4,6-trione
SMILESCCC1(C(=O)NC(=O)NC1=O)CCC(C)C
InChIInChI=1S/C11H18N2O3/c1-4-11(6-5-7(2)3)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)
InChIKeyVIROVYVQCGLCII-UHFFFAOYSA-N
CAS number57-43-2
UNIIGWH6IJ239E
PubChem CID2164
Pharmacokinetics[]
Elimination half-life8–42 hours
MetabolismHepatic
ExcretionRenal
Routes of administrationBy mouth, intramuscular, intravenous, rectal
Toxicity
[]
Mouse:
- oral: 345 mg/kg
Rat:
- oral: 250 mg/kg
- ip: 115 mg/kg /Amobarbital
- sc: 190 mg/kg
 [1]

Amobarbital (also known as Amylobarbitone, Isomytal, Amylobarbital, Barbamil, Barbamyl, Amytal, Amobarbitone, Amylbarbitone, Barbamyl acid or Pentymalum) is a substance of the barbiturate class.

Chemistry

Salts []

Amobarbital is typically found in the form of its sodium salt.

 []

Amobarbital is achiral.

Amobarbital matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

Amobarbital (like all barbiturates) works by binding to the GABAA receptor at either the alpha or the beta sub unit. These are binding sites that are distinct from GABA itself and also distinct from the benzodiazepine binding site. Like benzodiazepines, barbiturates potentiate the effect of GABA at this receptor. This GABAA receptor binding decreases input resistance, depresses burst and tonic firing, especially in ventrobasal and intralaminar neurons, while at the same time increasing burst duration and mean conductance at individual chloride channels; this increases both the amplitude and decay time of inhibitory postsynaptic currents. In addition to this GABA-ergic effect, barbiturates also block the AMPA receptor, a subtype of glutamate receptor. Glutamate is the principal excitatory neurotransmitter in the mammalian CNS. Amobarbital also appears to bind neuronal nicotinic acetylcholine receptors. [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

induction41 (1 contraindicated)
shared target33
shared target33
shared target33
shared target33
shared target33
shared target33
shared target33
shared target33
shared target33
shared target33
shared target33
shared target33
shared target33
shared target33
shared target33
shared target33

Medical side effects []

40 side effects listed on drug labels in (amobarbital).

  • Anaemia megaloblastic
  • Angioedema
  • Anxiety
  • Apnoea
  • Ataxia
  • Atelectasis
  • Pneumothorax
  • Confusional state
  • Feeling abnormal
  • Constipation
  • Dermatitis exfoliative
  • Dizziness
  • Syncope
  • Dermatitis
  • Rash
  • Body temperature increased
  • Hallucination
  • Headache
  • Hypersensitivity
  • Hypotension
  • Nausea
  • Nervousness
  • Tension
  • Nightmare
  • Shock
  • Loss of consciousness
  • Vomiting
  • Agitation
  • Hyperkinesia
  • Depressed level of consciousness
  • Injection site reaction
  • Hepatocellular injury
  • Liver injury
  • Thinking abnormal
  • Mental disability
  • Bradycardia
  • Somnolence
  • Hypoxia
  • Respiratory failure
  • Hypoventilation

Indications

  • Insomnia

 []

  • Brazil: Amobarbital is a B1.[3]
  • Canada: Amobarbital is a Schedule IV.
  • Germany: Amobarbital is a Anlage III under the "Betäubungsmittelgesetz (BtMG)".
  • United States: Amobarbital is a Schedule II / Schedule III under the "Controlled Substances Act".
  • United Kingdom: Amobarbital is a Class B under the "Misuse of Drugs Act 1971".
  • United Nations: Amobarbital is a Schedule III psychotropic under the "Convention on Psychotropic Substances 1971".
  • Other: Amobarbital is a SE: Förteckning IV.

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 2164, Amobarbital. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/2164
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Amobarbital. UNII: GWH6IJ239E. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/GWH6IJ239E
  3. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 18:01:25
drugspromissing (no DrugsPRO reagent data)2026-11-20 18:01:21
erowidmissing (no Erowid substance of that name)2026-11-20 18:01:21
gsrsok2026-11-20 18:01:22
hmdbmissing (hmdb.ca refused automated access to HMDB0015440)2026-11-20 18:01:21
keggok2026-11-20 18:01:23
pubchemok2026-11-20 18:01:21
redditmissing (no r/tripreports posts mention it)2026-11-20 18:01:21
siderok2026-11-20 18:01:21
structureok2026-11-20 18:01:21
wikipediaok2026-11-20 18:01:21